PIVA, ELISA
PIVA, ELISA
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: A report of three cases
2017 Visentin, Andrea; Imbergamo, Silvia; Frezzato, Federica; Pizzi, Marco; Bertorelle, Roberta; Scomazzon, Edoardo; Berno, Tamara; Riva, Marcello; Piva, Elisa; Facco, Monica; Piazza, Francesco; Semenzato, Gianpietro; Trentin, Livio
Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia
2017 Piccin, Andrea; Steurer, Michael; Feistritzer, Clemens; Murphy, Ciaran; Eakins, Elva; Van Schilfgaarde, Muriel; Corvetta, Daisy; Di Pierro, Angela Maria; Pusceddu, Irene; Marcheselli, Luigi; Gambato, Roberto; Langes, Martin; Veneri, Dino; Perbellini, Omar; Pacquola, Enrica; Gottardi, Michele; Gherlinzoni, Filippo; Mega, Andrea; Tauber, Martina; Mazzoleni, Guido; Piva, Elisa; Plebani, Mario; Krampera, Mauro; Gastl, Günther
Performance specifications of critical results management
2017 Piva, Elisa; Sciacovelli, Laura; Pelloso, Michela; Plebani, Mario
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents
2017 Schiavinato, Alvise; Zanetto, Alberto; Pantano, G; Tosato, Francesca; Nabergoj, Mitja; Fogar, Paola; Piva, Elisa; Gambato, Martina; Franceschet, Enrica; Floreani, Annarosa; Farinati, Fabio; Burra, Patrizia; Russo, FRANCESCO PAOLO; Plebani, Mario
Laboratory Critical Values Should Support Effective Clinical Decision Making
2016 Piva, Elisa; Plebani, Mario; Doering, Travis A; Crawford, James M; Plapp, Frederick
A case of eosinophilic disorder that evolved in acute lymphoblastyc leukemia.
2015 Schiavinato, A; Piva, Elisa; Pantano, G; Cornoldi, P; Nabergoj, M; Plebani, Mario
Clinical utility of reticulocyte parameters.
2015 Piva, Elisa; Brugnara, C; Spolaore, F; Plebani, Mario
Complete blood count at the ED: Preanalytic variables for hemoglobin and leukocytes
2015 Carraro, Paolo; Vettore, Gianna; Padoan, Andrea; Piva, Elisa; Plebani, Mario
Laboratory critical values: automated notification supports effective clinical decision making.
2014 Piva, Elisa; Pelloso, Michela; Penello, Laura; Plebani, Mario
Critical results communication: still an open issue.
2013 Piva, Elisa; Plebani, Mario
From "panic" to "critical" values: which path toward harmonization?
2013 Piva, Elisa; Plebani, Mario
Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: In vitro evaluation of rituximab hypersensitivity by basophil activation test.
2012 Piva, Elisa; Chieco Bianchi, F; Krajcar, V; Aversa, S; Plebani, Mario
Critical laboratory results: communication is just one of the problems.
2012 Plebani, Mario; Zaninotto, Martina; Sciacovelli, Laura; Piva, Elisa
The role of automated analyzers in detecting abnormal granulation of leucocytes in lysosomal storage diseases: Maroteaux-Lamy disease.
2012 Piva, Elisa; Pelloso, M; Ciubotaru, D; Penello, L; Burlina, Angelo; Plebani, Mario
Notification of abnormal and critical values: the road ahead.
2010 Piva, Elisa; Lippi, G; Plebani, Mario
Jordans' anomaly in a new neutral lipid storage disease.
2009 Piva, Elisa; Pajola, R; Binotto, G; Plebani, Mario
A new turbidimetric standard to improve the quality assurance of the erythrocyte sedimentation rate measurement.
2007 Piva, Elisa; Pajola, R; Temporin, V; Plebani, Mario
Determination of the length of sedimentation reaction (erythrocyte sedimentation rate) in non-anticoagulated blood with the Microtest 1
2002 Piva, Elisa; Fassina, P; Plebani, Mario
Erythrocyte sedimentation rate - Use of fresh blood for quality control
2002 Plebani, Mario; Piva, Elisa
Length of sedimentation reaction in undiluted blood (erythrocyte sedimentation rate): Variations with sex and age and reference limits
2001 Piva, Elisa; Sanzari, MARIA COLOMBA; Servidio, G; Plebani, Mario